Kotak Mahindra Capital Company Ltd ("Manager to the Offer") has submitted to BSE a copy of Detailed Public Statementin terms of Regulations 3(1), 4, 5(1), read with 13(4), 14(3) and 15(2) and other applicable provisions of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and subsequent amendments thereto to the public shareholders of Astec Lifesciences Ltd ("Target Company").